COVID-19: Pfizer jab recipients have lower antibodies targeting Indian variant, study suggests
People who have received the Pfizer/BioNTech vaccine have fewer antibodies targeting the Indian COVID-19 variant compared to other strains, new data suggests.
The full article is no longer available.
